11.71
price up icon2.72%   0.31
after-market アフターアワーズ: 11.63 -0.08 -0.68%
loading
前日終値:
$11.40
開ける:
$11.4
24時間の取引高:
4.67M
Relative Volume:
0.99
時価総額:
$1.26B
収益:
$45.97M
当期純損益:
$-508.80M
株価収益率:
-2.1369
EPS:
-5.48
ネットキャッシュフロー:
$-382.65M
1週間 パフォーマンス:
+2.54%
1か月 パフォーマンス:
+1.91%
6か月 パフォーマンス:
+23.92%
1年 パフォーマンス:
-45.84%
1日の値動き範囲:
Value
$11.34
$12.46
1週間の範囲:
Value
$11.06
$12.46
52週間の値動き範囲:
Value
$5.90
$23.76

Intellia Therapeutics Inc Stock (NTLA) Company Profile

Name
名前
Intellia Therapeutics Inc
Name
セクター
Healthcare (1150)
Name
電話
857-285-6200
Name
住所
40 ERIE STREET, CAMBRIDGE, MA
Name
職員
598
Name
Twitter
@intelliatweets
Name
次回の収益日
2024-11-07
Name
最新のSEC提出書
Name
NTLA's Discussions on Twitter

NTLA を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
NTLA
Intellia Therapeutics Inc
11.71 1.22B 45.97M -508.80M -382.65M -5.48
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
396.62 102.81B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
563.80 61.25B 14.21B 4.46B 3.56B 39.68
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
447.43 58.59B 2.46B -319.09M -52.09M -2.47
Biotechnology icon
ARGX
Argen X Se Adr
722.01 43.23B 3.06B 1.28B 447.35M 21.30
Biotechnology icon
ONC
Beone Medicines Ltd Adr
336.26 36.53B 3.81B -644.79M -669.77M -6.24

Intellia Therapeutics Inc Stock (NTLA) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2025-04-21 アップグレード Wolfe Research Peer Perform → Outperform
2025-03-05 開始されました H.C. Wainwright Buy
2025-02-28 ダウングレード Goldman Neutral → Sell
2025-02-28 ダウングレード JP Morgan Overweight → Neutral
2025-01-27 ダウングレード Morgan Stanley Overweight → Equal-Weight
2024-02-23 ダウングレード Goldman Buy → Neutral
2024-02-15 開始されました Wolfe Research Peer Perform
2023-04-13 開始されました Canaccord Genuity Buy
2023-03-21 開始されました Bernstein Outperform
2023-03-14 アップグレード BMO Capital Markets Market Perform → Outperform
2023-02-01 開始されました Cantor Fitzgerald Overweight
2023-01-24 アップグレード Citigroup Sell → Neutral
2023-01-19 ダウングレード JMP Securities Mkt Outperform → Mkt Perform
2022-10-11 開始されました Morgan Stanley Overweight
2022-09-21 開始されました JP Morgan Overweight
2022-09-01 開始されました Citigroup Sell
2022-06-17 開始されました BMO Capital Markets Market Perform
2022-06-16 開始されました BofA Securities Buy
2022-04-28 開始されました Credit Suisse Outperform
2022-02-18 開始されました William Blair Outperform
2022-02-07 アップグレード Oppenheimer Perform → Outperform
2022-01-31 開始されました Cowen Outperform
2022-01-07 開始されました Piper Sandler Overweight
2021-10-05 開始されました Guggenheim Buy
2021-09-24 開始されました Stifel Buy
2021-06-28 繰り返されました H.C. Wainwright Buy
2021-06-11 開始されました H.C. Wainwright Buy
2021-05-07 アップグレード ROTH Capital Neutral → Buy
2021-05-04 開始されました RBC Capital Mkts Outperform
2021-03-04 開始されました JMP Securities Mkt Outperform
2020-12-22 ダウングレード Robert W. Baird Outperform → Neutral
2020-10-27 開始されました Truist Buy
2020-10-14 開始されました Wells Fargo Overweight
2020-09-18 開始されました Goldman Buy
2020-02-28 アップグレード Oppenheimer Perform → Outperform
2020-02-14 ダウングレード Wedbush Outperform → Neutral
2019-11-01 アップグレード Raymond James Mkt Perform → Outperform
2019-07-09 開始されました Robert W. Baird Outperform
2019-06-10 開始されました ROTH Capital Neutral
2019-05-03 アップグレード Wedbush Neutral → Outperform
2019-04-12 開始されました Evercore ISI Outperform
2018-11-02 ダウングレード Wedbush Outperform → Neutral
2018-10-29 開始されました Credit Suisse Neutral
2018-09-21 開始されました Raymond James Mkt Perform
2018-05-15 アップグレード Chardan Capital Markets Neutral → Buy
2018-03-08 開始されました JMP Securities Mkt Outperform
2017-11-01 繰り返されました Jefferies Buy
2017-06-22 再開されました Jefferies Buy
2017-03-28 開始されました Chardan Capital Markets Buy
2016-08-05 アップグレード Jefferies Hold → Buy
すべてを表示

Intellia Therapeutics Inc (NTLA) 最新ニュース

pulisher
08:06 AM

Cathie Wood’s ARK ETF adjusts portfolio, sells Roku stock, buys CRISPR and Intellia - Investing.com

08:06 AM
pulisher
10:49 AM

Panic Selling: Is Intellia Therapeutics Inc. benefiting from interest rate changesJuly 2025 Drop Watch & Verified High Yield Trade Plans - khodrobank.com

10:49 AM
pulisher
10:33 AM

Signal strength of Intellia Therapeutics Inc. stock in tech scannersQuarterly Earnings Report & Safe Capital Growth Tips - Newser

10:33 AM
pulisher
08:42 AM

Does Intellia Therapeutics Inc. stock have upside surprise potentialJuly 2025 Big Picture & Real-Time Buy Zone Alerts - khodrobank.com

08:42 AM
pulisher
08:01 AM

Real time alert setup for Intellia Therapeutics Inc. performanceJuly 2025 Snapshot & High Accuracy Trade Alerts - Newser

08:01 AM
pulisher
07:52 AM

How to forecast Intellia Therapeutics Inc. trends using time series2025 Support & Resistance & High Yield Stock Recommendations - Newser

07:52 AM
pulisher
06:52 AM

Intellia Therapeutics Inc. stock outlook for YEARPortfolio Growth Summary & Weekly Sector Rotation Insights - Newser

06:52 AM
pulisher
03:47 AM

Leading vs lagging indicators on Intellia Therapeutics Inc. performanceWall Street Watch & Fast Gaining Stock Strategy Reports - Newser

03:47 AM
pulisher
03:06 AM

What the charts say about Intellia Therapeutics Inc. todayPortfolio Value Report & Stepwise Swing Trade Plans - Newser

03:06 AM
pulisher
02:01 AM

Tools to assess Intellia Therapeutics Inc.’s risk profileQuarterly Trade Report & Expert Verified Stock Movement Alerts - Newser

02:01 AM
pulisher
Sep 02, 2025

Why Intellia Therapeutics Inc. is moving today2025 EndofYear Setup & Safe Capital Investment Plans - Newser

Sep 02, 2025
pulisher
Sep 02, 2025

Multi asset correlation models including Intellia Therapeutics Inc.Profit Target & Daily Oversold Stock Bounce Ideas - Newser

Sep 02, 2025
pulisher
Sep 02, 2025

Merger Talk: Is Intellia Therapeutics Inc. benefiting from interest rate changesEarnings Performance Report & Stepwise Trade Signal Implementation - khodrobank.com

Sep 02, 2025
pulisher
Sep 02, 2025

Is Intellia Therapeutics Inc. stock reversal real or fakeJuly 2025 Highlights & Real-Time Market Sentiment Alerts - Newser

Sep 02, 2025
pulisher
Sep 02, 2025

How hedge fund analytics apply to Intellia Therapeutics Inc. stockWeekly Stock Recap & High Return Stock Watch Alerts - Newser

Sep 02, 2025
pulisher
Sep 02, 2025

Will Intellia Therapeutics Inc. outperform tech stocksMarket Activity Report & Technical Buy Zone Confirmation - khodrobank.com

Sep 02, 2025
pulisher
Sep 02, 2025

What’s next for Intellia Therapeutics Inc. stockMarket Sentiment Report & Real-Time Stock Price Movement Reports - khodrobank.com

Sep 02, 2025
pulisher
Sep 02, 2025

Beat the Market the Zacks Way: Oracle, Intellia, Pharming Group in Focus - TradingView

Sep 02, 2025
pulisher
Sep 02, 2025

Gene Editing Market to Surpass USD 15.46 Billion by 2032, Fueled by Breakthroughs in CRISPR Technology and Precision Medicine – SNS Insider - GlobeNewswire Inc.

Sep 02, 2025
pulisher
Sep 02, 2025

Intellia Therapeutics Inc. Stock Flags Risk Zone in Volatility Index getLinesFromResByArray error: size == 0 - thegnnews.com

Sep 02, 2025
pulisher
Sep 02, 2025

Aug Levels: What’s next for Intellia Therapeutics Inc. stockInsider Selling & Short-Term Trading Opportunity Alerts - khodrobank.com

Sep 02, 2025
pulisher
Sep 02, 2025

Is Intellia Therapeutics Inc. building a consolidation base2025 EndofYear Setup & Safe Capital Investment Plans - Newser

Sep 02, 2025
pulisher
Sep 02, 2025

Pattern recognition hints at Intellia Therapeutics Inc. upside2025 Market WrapUp & High Accuracy Swing Entry Alerts - Newser

Sep 02, 2025
pulisher
Sep 02, 2025

Why is Intellia Therapeutics Inc. stock going upJuly 2025 Update & High Accuracy Trade Signal Alerts - khodrobank.com

Sep 02, 2025
pulisher
Sep 01, 2025

Is Intellia Therapeutics Inc. stock good for income investorsPortfolio Performance Report & Consistent Profit Trade Alerts - خودرو بانک

Sep 01, 2025
pulisher
Sep 01, 2025

Insider Buy: Can Intellia Therapeutics Inc. navigate macro headwindsWeekly Trade Recap & Weekly Top Performers Watchlists - khodrobank.com

Sep 01, 2025
pulisher
Sep 01, 2025

Why big players are pouring millions in THIS biotech stock - TradingView

Sep 01, 2025
pulisher
Sep 01, 2025

Key metrics from Intellia Therapeutics Inc.’s quarterly dataJuly 2025 EndofMonth & Risk Controlled Daily Trade Plans - Newser

Sep 01, 2025
pulisher
Aug 31, 2025

Intellia Therapeutics Inc. stock chart pattern explainedJuly 2025 Review & Weekly High Potential Stock Alerts - Newser

Aug 31, 2025
pulisher
Aug 31, 2025

Applying sector rotation models to Intellia Therapeutics Inc.Trade Entry Report & Fast Entry High Yield Stock Tips - Newser

Aug 31, 2025
pulisher
Aug 31, 2025

Intellia Therapeutics Inc. stock prediction for this week2025 Investor Takeaways & High Accuracy Swing Entry Alerts - Newser

Aug 31, 2025
pulisher
Aug 31, 2025

Using Python tools to backtest Intellia Therapeutics Inc. strategiesJuly 2025 Breakouts & AI Powered Market Trend Analysis - Newser

Aug 31, 2025
pulisher
Aug 31, 2025

Chart based analysis of Intellia Therapeutics Inc. trendsJuly 2025 Patterns & Safe Entry Momentum Tips - Newser

Aug 31, 2025
pulisher
Aug 31, 2025

ARK Investment buys 560K shares of Intellia Therapeutics - MSN

Aug 31, 2025
pulisher
Aug 31, 2025

Detecting support and resistance levels for Intellia Therapeutics Inc.Portfolio Risk Summary & Low Drawdown Trading Techniques - Newser

Aug 31, 2025
pulisher
Aug 31, 2025

Is Intellia Therapeutics Inc. a candidate for recovery playJuly 2025 Institutional & Scalable Portfolio Growth Methods - Newser

Aug 31, 2025
pulisher
Aug 30, 2025

Will Intellia Therapeutics Inc. bounce back from current support2025 Dividend Review & Risk Controlled Daily Trade Plans - Newser

Aug 30, 2025
pulisher
Aug 30, 2025

Is Intellia Therapeutics Inc. trending in predictive chart modelsOil Prices & Free Technical Confirmation Trade Alerts - Newser

Aug 30, 2025
pulisher
Aug 30, 2025

Cathie Wood Invests $4M in Intellia Therapeutics, Trims Stakes in Roku and DraftKings - AInvest

Aug 30, 2025

Intellia Therapeutics Inc (NTLA) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$86.96
price up icon 1.14%
$27.08
price up icon 4.60%
$23.52
price down icon 1.34%
$100.42
price down icon 0.20%
$143.50
price down icon 1.24%
biotechnology ONC
$336.26
price up icon 1.27%
大文字化:     |  ボリューム (24 時間):